发明名称 |
Arylpiperazinyl compounds |
摘要 |
The invention relates to 5-HT receptor agonists or antagonists. Novel arylpiperazinyl sulfonamide compounds represented by Formula I, and synthesis and uses thereof for treating diseases including those mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as generalized anxiety disorder, ADD/ADHD, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
|
申请公布号 |
US2004220192(A1) |
申请公布日期 |
2004.11.04 |
申请号 |
US20040768579 |
申请日期 |
2004.01.30 |
申请人 |
DHANOA DALE S.;CHEN DONGLI;BECKER OREN;NOIMAN SILVIA;CHERUKU SRINIVASA RAO;MARANTZ YAEL;SHARADENDU ANURAG;SHACHEM SHARON;HEIFETZ ALEXANDER;MOHANTY PRADYUMNA;INBAL BOAZ;FICHMAN MERAV;NUDELMAN RAPHAEL;BAR-HAIM SHAY |
发明人 |
DHANOA DALE S.;CHEN DONGLI;BECKER OREN;NOIMAN SILVIA;CHERUKU SRINIVASA RAO;MARANTZ YAEL;SHARADENDU ANURAG;SHACHEM SHARON;HEIFETZ ALEXANDER;MOHANTY PRADYUMNA;INBAL BOAZ;FICHMAN MERAV;NUDELMAN RAPHAEL;BAR-HAIM SHAY |
分类号 |
A61K31/495;A61K31/496;A61K31/497;A61K31/506;C07D;C07D211/96;C07D213/74;C07D239/42;C07D295/13;C07D401/02;C07D401/04;C07D401/12;C07D403/02;(IPC1-7):C0743/14 |
主分类号 |
A61K31/495 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|